Blærekræft

Keyphrases

• Bladder Cancer 100%
• Europe 33%
• Invasive Procedures 33%
• Radical Surgery 33%
• 5-year Survival 33%
• Survivors 33%
• Radiation Therapy 33%
• Metastatic Disease 33%
• Chemoimmunotherapy 33%
• Systemic Chemotherapy 33%
• Health Care Costs 33%
• Bladder Cancer Diagnosis 33%
• Quality of Life Issues 33%
• Non-muscle Invasive Bladder Cancer (NMIBC) 33%
• Bladder Recurrence 33%
• Long-term Quality of Life 33%
• Muscle-invasive Disease 33%
• Recurrence Treatment 33%
• Recurrence Surveillance 33%

Medicine and Dentistry

• Bladder Cancer 100%
• Quality of Life 33%
• Malignant Neoplasm 33%
• Radiation Therapy 33%
• Metastatic Carcinoma 33%
• Invasive Procedure 33%
• Health Care Cost 33%
• Radical Surgery 33%
• Overall Survival 33%
• Cancer Epidemiology 33%
• Immunotherapy 33%
• Non Muscle Invasive Bladder Cancer 33%
• Cancer Recurrence Treatment 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Bladder Cancer 100%
• Malignant Neoplasm 33%
• Overall Survival 33%
• Chemotherapy 33%
• Metastasis 33%
• Immunotherapy 33%
• Cancer Recurrence 33%
• Cancer Epidemiology 33%
• Non Muscle Invasive Bladder Cancer 33%